IOVA Exercise Disclosure
Roche Corleen M. · SEC Form 4 · Filed Aug 10, 2026
Exercise
Calculated transaction value
$0
Roche Corleen M. Chief Financial Officer
IOVA
Transaction date
Aug 6, 2026
Public filing date
Aug 10, 2026
Filing lag
Filed 4 days later
IOVA daily price context
Close on/before transaction
$6.21
Aug 6, 2026
Close before public filing
$6.34
Aug 7, 2026
Return since public filing
+48.26%
Through Sep 15, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 49,995 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001104659-26-093482
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$131.89K
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Iovance Biotherapeutics, Inc. IOVA Current | Exercise | Aug 6, 2026 | $0 |
| Iovance Biotherapeutics, Inc. IOVA | Disposition | Aug 6, 2026 | $131.89K |
| Iovance Biotherapeutics, Inc. IOVA | Exercise | Aug 6, 2026 | $0 |